SCHEMBL16558589

SCHEMBL16558589

CN[C@@H](Cc1cnc[nH]1)C(=O)S

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.50
▸ SLC7A5 Q01650 1/20 0.50
▸ ITGB2 P05107 3/20 0.49
▸ ICAM1 P05362 3/20 0.49
▸ ITGAL P20701 3/20 0.49
▸ ALDH1A1 P00352 6/20 0.47
▸ HRH4 Q9H3N8 4/20 0.47
▸ HRH3 Q9Y5N1 4/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ GLA P06280 1/20 0.47
▸ THPO P40225 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ QPCT Q16769 1/20 0.45
▸ QPCTL Q9NXS2 1/20 0.45
▸ GABRA1 P14867 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1641647 0.86 CYP3A4 (0.51) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL27043238 0.86 ITGB2 (0.60) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL13979576 0.86 CYP3A4 (0.51) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL15119370 0.86 CYP3A4 (0.51) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL151336 0.86 ITGB2 (0.60) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL163397 0.86 ITGB2 (0.60) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL31326521 0.84 CYP3A4 (0.54) CYP3A4SLC7A5ITGB2ICAM1ITGAL
Hydrochloric Acid SCHEMBL11744091 0.84 ITGB2 (0.59) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL14490956 0.84 CYP3A4 (0.54) CYP3A4SLC7A5ITGB2ICAM1ITGAL
SCHEMBL13897023 0.83 CYP3A4 (0.49) CYP3A4SLC7A5ITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150071861-A1 POLYMER, CONTRAST AGENT FOR NUCLEAR MAGNETIC RESONANCE ANALYSIS OR MAGNETIC RESONANCE IMAGING USING THE POLYMER, COMPOUND AND METHOD OF NUCLEAR MAGNETIC RESONANCE ANALYSIS AND METHOD OF MAGNETIC RESONANCE IMAGING USING THE POLYMER CANON KABUSHIKI KAISHA (JP) 2015-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150071861-A1 POLYMER, CONTRAST AGENT FOR NUCLEAR MAGNETIC RESONANCE ANALYSIS OR MAGNETIC RESONANCE IMAGING USING THE POLYMER, COMPOUND AND METHOD OF NUCLEAR MAGNETIC RESONANCE ANALYSIS AND METHOD OF MAGNETIC RESONANCE IMAGING USING THE POLYMER PHOSPHO1, NPPA, NMRAL1 CYP3A4 4535/4885SLC7A5 1655/4885ITGB2 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback